The global assisted reproductive technology market size is expected to reach USD 54.75 Billion at a steady revenue CAGR of 9.7% in 2028, according to latest analysis by Emergen Research.
The global assisted reproductive technology market size is expected to reach USD 54.75 Billion at a steady revenue CAGR of 9.7% in 2028, according to latest analysis by Emergen Research. Rising prevalence of infertility is one of the prominent factors driving the growth of this market. According to a report published by National Institute for Health and Welfare, Finland, in 2018, around 1 in 8 couples globally were affected with fertility problems. Furthermore, technological advancements enabling effective management of infertility are also attributable to the expansion of this market. For instance, in August 2020, the U.S. FDA approved a new in vitro fertilization (IVF) device for the management of female infertility. It is a handheld, battery operated device that aspirates eggs during ovum pickup procedure. Such developments are likely to foster market growth in the forthcoming years.
Infertility is a multi-faceted issue that can be caused by a single factor or a combination of factors. It affects both men and women, and its prevalence is increasing globally. According to the World Health Organization (WHO), infertility affects 15% of couples worldwide. Growing incidence of ovulation problems, endometriosis, blockages in the reproductive tract, and other issues are some of the major factors contributing to the growth of the global assisted reproductive technology (ART) market.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/165
ART is a process used to achieve pregnancy by artificial or partially artificial means. It is an umbrella term that includes fertility treatments such as in-vitro fertilization (IVF), gamete intrafallopian transfer (GIFT), and zygote intrafallopian transfer (ZIFT). ART is used when other fertility treatments have failed or when there are genetic abnormalities that need to be considered.
Some Key Highlights from the Report
- In June 2020, Ferring Pharmaceuticals announced the launch of its new product, Pergoveris, in the U.S. Pergoveris is a combination therapy used for the treatment of female infertility. The product is a mix of follicle-stimulating hormone (FSH) and luteinizing hormone (LH). Ferring Pharmaceuticals is a Switzerland-based biopharmaceutical company.
- On the basis of treatment type, the market has been classified into intrauterine insemination (IUI), in vitro fertilization (IVF), donor services, third party reproduction, artificial insemination (AI), and others. The IVF segment is expected to hold the largest market share over the forecast period. Increasing number of IVF cycles performed globally is one of the key factors accountable for this segmental growth. According to a report published by National Institute for Health and Welfare, Finland, in 2018, around 1 million IVF cycles were performed worldwide.
- On the basis of end user, the market has been classified into fertility clinics, academic & research institutes, and hospitals. The fertility clinics segment is expected to expand at a rapid pace over the forecast period. This can be attributed to several factors such as rising number of fertility clinics globally, availability of advanced options for fertility management, and favorable reimbursement policies in developed countries. For instance, as per a report by the Centers for Disease Control and Prevention, in the U.S., there were 811 fertility clinics in 2015 as against 456 fertility clinics in 2005. Furthermore, according to a report published by National Institute for Health and Welfare, Finland, in 2016, around 3% of all babies born globally were conceived with assisted reproductive technology.
- Frozen non-donor segment revenue is expected to register a significantly rapid growth rate during the forecast period due to the rising preference for frozen embryos and gametes by Infertility clinics. Also, the segment accounts for a relatively higher market share as compared to fresh non-donor segments. This is expected to support the growth of this segment over the forecast period.
- On the basis of geography, the market has been classified into North America, Europe, Asia Pacific, Latin America, Middle East & Africa. North America is expected to account for the largest market share over the forecast period. This can be attributed to factors such as rising prevalence of infertility and early adoption of advanced technologies in this region. For instance, according to a report published by National Institute for Health and Welfare, Finland, in 2018, around 1 in 8 couples globally were affected with fertility problems. Furthermore, availability of advanced treatment options and favorable reimbursement policies are also expected to contribute to market growth in this region.
- Some major players in the market report include Origio, Cryolab Ltd., Bloom IVF Center, Ferring Pharmaceuticals, Cosmos Biomedical, Irvine Scientific, European Sperm Bank, Ovascience, Parallabs, and Microm UK Ltd.
Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/assisted-reproductive-technology-market
Emergen Research has segmented the global assisted reproductive technology market on the basis of procedure, technology, end-use, and region:
Procedure Outlook (Revenue, USD Billion; 2018-2028)
- Fresh Donor
- Fresh Non-Donor
- Frozen Donor
- Frozen Non-Donor
- Egg/Embryo Banking
Technology Outlook (Revenue, USD Billion; 2018-2028)
- In-Vitro Fertilization (IVF)
- In-Vitro Fertilization (IVF) with Intracytoplasmic Sperm Injection (ICSI)
- In-Vitro Fertilization (IVF) without Intracytoplasmic Sperm Injection (ICSI)
- Artificial Insemination
- Frozen Embryo Transfer (FET)
- Others
End-Use Outlook (Revenue, USD Billion; 2018-2028)
- Hospitals
- Fertility Clinics
- Others
Regional Outlook (Revenue, USD Billion; 2018–2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Spain
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- Rest Of MEA
Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/165
Explore More Reports Emergen Research:
Fiber Reinforced Polymer Rebar Market
Industrial Control System Security Market
automotive cybersecurity market
Automotive Data Monetization Market
Electric Vehicle Ecosystem Market
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend’s existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Emergen Research Media Citations: https://www.emergenresearch.com/media-citations
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Press Release Available @ https://www.emergenresearch.com/press-release/global-assisted-reproductive-technology-market